BDR Pharma launches generic Palbociclib for breast cancer treatment
The drug will be made available in three strengths i.e. – 125 mg, 100 mg and 75 mg capsules priced at Rs 3,150 for 75 mg; Rs 3,600…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
fulvestrant
New Novartis data show Piqray effectiveness across key biomarkers in patients with HR+/HER2-…
Biomarker analysis from phase-III Solar-1 study shows Piqray plus fulvestrant had clinical benefit regardless of presence of ESR1…